Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / SHS USD
-
Number of holders
-
447
-
Total 13F shares, excl. options
-
57.4M
-
Shares change
-
-233K
-
Total reported value, excl. options
-
$6.13B
-
Value change
-
-$45.7M
-
Put/Call ratio
-
0.98
-
Number of buys
-
210
-
Number of sells
-
-244
-
Price
-
$106.73
Significant Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2024
550 filings reported holding JAZZ - Jazz Pharmaceuticals plc - SHS USD as of Q2 2024.
Jazz Pharmaceuticals plc - SHS USD (JAZZ) has 447 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.4M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (6.32M shares), BlackRock Inc. (6.15M shares), LSV ASSET MANAGEMENT (2.48M shares), Capital World Investors (2.02M shares), STATE STREET CORP (2.02M shares), Pacer Advisors, Inc. (1.82M shares), JPMORGAN CHASE & CO (1.54M shares), Vestal Point Capital, LP (1.5M shares), AMERIPRISE FINANCIAL INC (1.46M shares), and Polaris Capital Management, LLC (1.38M shares).
This table shows the top 447 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.